Hypertension Canada. Canadian Hypertension Education Program (CHEP)2014Recommendations. Available: www.hypertension.ca/en/chep (accessed April 7, 2014).
2.
Chisholm-BurnsMAKim LeeJSpiveyCA. US pharmacists’ effect as team members on patient care: systematic review and meta-analyses. Med Care2010;48:923-33.
3.
SantschiVChioleroABurnandB. Impact of pharmacist care in the management of cardiovascular disease risk factors: s systematic review and meta-analysis of randomized trials. Arch Intern Med2011;171:1441-53.
4.
SantschiVChioleroAParadisG. Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Care2012;35:2706-17.
5.
HouleSKDTsuyukiRTCampbellNRC. The Canadian Hypertension Education Program (CHEP) 2011 guidelines for pharmacists. Can Pharm J (Ott)2011;144:295-304.
6.
HouleSKDPadwalRTsuyukiRT. The 2012-2013 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: an update. Can Pharm J (Ott)2013;146:146-50.
7.
BeckettNSPetersRFletcherAE., for the HYVET study group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med2008;358:1887-98.
8.
LewingtonSClarkeRQizilbashN.; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet2002;360(9349):1903-13.
9.
D’AgostinoRBBelangerAJKannelWBCruickshankJM.Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study. BMJ1991;303:385.
10.
CruickshankJM.Clinical importance of coronary perfusion pressure in the hypertensive patient with left ventricular hypertrophy. Cardiology1992;81:283-90.
11.
MesserliFHPanjrathGS.The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential?J Am Coll Cardiol2009; 54:1827-34.
12.
RabkinSWWaheedAPoulterRSWoodD.Myocardial perfusion pressure in patients with hypertension and coronary artery disease: implications for DBP targets in hypertension management. J Hypertens2013;31:975-82.
13.
HeFJLiJMacGregorGA.Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ2013;346:f1325.
14.
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes2013;37(suppl 1):S1-S212.
15.
BennettCMGuoMDharmageSC.HbA(1c) as a screening tool for detection of type 2 diabetes: a systematic review. Diabet Med2007;24:333-43.
16.
HuYLiuWChenY. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance. Acta Diabetol2010;47:231-6.
17.
HanssonLZanchettiACarruthersSG. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet1998;351:1755-62.
18.
CalongeNPetittiDBDeWittTGGordisL.Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med2009;150:396-404.
19.
RothwellPMFowkesFGBelchJF. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet2011;377(9759):31-41.
20.
VandvikPOLincoffAMGoreJM. Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest2012;141(2 Suppl):e637S-e668S.
21.
McAlisterFAWilkinsKJoffresM. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades. CMAJ2011;183:1007-13.
22.
HouleSKDCampbellNRCTsuyukiRT. Home blood pressure monitoring plays a key role in hypertension management: review of applications, effectiveness and technique for pharmacists. Can Pharm J (Ott)2011;141:18-20.
